News
After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...
45m
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauIn the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...
IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...
The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.
23h
The Healthy @Reader's Digest on MSNMusic Duo The War and Treaty on Managing His Type 2 Diabetes—and Getting Healthier TogetherThe Grammy-nominated musicians discuss what's helping them manage, and why they’re using their platform to reach the Black ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
Oral semaglutide was associated with more pronounced cardiovascular benefits among patients with higher baseline HbA1c in ...
Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is ...
In the realm of diabetes management and diagnosis, two tests often come into focus: the fasting glucose test and the A1c test. Both are crucial tools in assessing blood sugar levels, but they serve ...
Concurrent hypertension and type 2 diabetes elevated mortality risks more than either condition alone among adults in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results